Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

35 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies

NCT03397706

Conditions
Epstein-Barr Virus-Associated Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +3 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • UC Irvine Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

NCT03744676

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Local Institution - 0057 Los Angeles, California, United States
  • Local Institution - 0060 Denver, Colorado, United States
  • Local Institution - 0089 Miami, Florida, United States
  • Local Institution - 0081 Orlando, Florida, United States
View all 23 locations
View Trial Details

Related conditions